Study finds new medication can significantly block early stages of COVID-19 in engineered human tissues
By Ana Gajic An international team of researchers led by University of British Columbia and in collaboration with St. Michael’s Hospital has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts. The findings, published today in Cell, hold promise as a treatment capable of stopping early infection of the novel… Read More »
